Genmab US, Inc.
Member Type
Associate
Organization Type
Manufacturer
Description
Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 25 years, Genmab has pioneered next-generation antibody technologies and leveraged translational research and data sciences to build a differentiated portfolio and pipeline of antibody medicines. Today, Genmab is evolving into a fully integrated biotechnology company, with capabilities spanning discovery and development through commercialization. Its portfolio includes marketed medicines and a robust pipeline of investigational therapies across hematologic malignancies and solid tumors. Genmab also has a strong history of strategic partnerships with leading biotechnology and pharmaceutical companies to help develop and deliver novel antibody therapies to patients. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab’s 2030 vision is for its Knock-Your- Socks-Off (KYSO®) antibody medicines to fundamentally transform the lives of people with cancer and other serious diseases.
Contact Information
777 Scudders Mill Road
Plainsboro, NJ 08536
https://www.genmab.com/(609)430-2481
Services Offered
Branded
Staff
-
Avalos, Javier
Sr. Director Trade, Distribution and Supply Chain, Genmab US, Inc. -
Fallone, Jenny
Director, Trade and Channel Strategy, Genmab US, Inc. -
Graybill, Ron
Vice President, Market Access, Genmab US, Inc. -
Hybner, Shannon
Director, Trade and Channel Strategy , Genmab US, Inc. -
Shenouda, Rosemary
Acting Director, Trade and Channel Strategy, Genmab US, Inc.
- of 1